Role of Salvage Radiation Treatment of Relapses in Relapsed/Refractory Diffuse Large B Cell Lymphoma Post Autologous Stem Cell Transplant.

[1]  M. Pasquini,et al.  Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis , 2021, Blood advances.

[2]  Y. Khafaga,et al.  Impact of Radiation Therapy After High Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients With Relapsed/Refractory Lymphomas: A Single Center Experience. , 2021, Clinical lymphoma, myeloma & leukemia.

[3]  Michael L. Wang,et al.  Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study , 2020, The Lancet.

[4]  H. Prince,et al.  A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03). , 2019, International journal of radiation oncology, biology, physics.

[5]  Juliet Investigators.  Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma , 2019 .

[6]  I. Flinn,et al.  Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial. , 2019, The Lancet. Oncology.

[7]  A. Ng,et al.  Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group. , 2018, International journal of radiation oncology, biology, physics.

[8]  J. Friedberg,et al.  Late Relapses After High‐dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Diffuse Large B‐cell Lymphoma in the Rituximab Era , 2017, Clinical lymphoma, myeloma & leukemia.

[9]  R. Mick,et al.  Outcomes of patients with relapsed/refractory diffuse large B‐cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era , 2013, American journal of hematology.

[10]  J. Friedberg,et al.  High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era , 2012, Leukemia & lymphoma.

[11]  J. Friedberg,et al.  Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era. , 2010, International journal of radiation oncology, biology, physics.

[12]  A. Hagenbeek,et al.  Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. , 1995, The New England journal of medicine.